Eledon shares jump after FDA fast-track designation for kidney treatment
Eledon Pharmaceuticals said the Food and Drug Administration granted fast-track designation for its kidney treatment. The stock rose 13% to $3.04 on Tuesday and is up 87% this year.
Eledon Pharmaceuticals said its kidney treatment was granted fast-track designation by the Food and Drug Administration. 04 on Tuesday. Shares are up 87% this year. Patients treated with tegoprubart in a Phase 2 trial had sta…